论文部分内容阅读
2012年10月20日,中华医学会第三次全国肝纤维化、肝硬化学术会议在河南郑州举行。会上选举产生了第六届中华医学会肝病学分会委员会。北京大学人民医院副院长、北京大学肝病研究所所长、我刊副主编魏来教授荣任第六届中华医学会肝病学分会主任委员。魏来,男,1961年11月出生,医学博士。现任北京大学人民医院副院长,北京大学肝病研究所所长,“丙型肝炎和肝病免疫治疗”北京市重点实验室主任,北京大学人民医院肝病科主任,教授,主任医师,博士生导师。并任中国医药生物技术协会常务理事,卫生部全国临床检验标准委员会临床应用准则
On October 20, 2012, the third national conference of Chinese Medical Association on Liver Fibrosis and Cirrhosis was held in Zhengzhou, Henan. At the meeting, the sixth session of the Chinese Society of Hepatology Branch committee was elected. Peking University People’s Hospital, vice president of Peking University Institute of Liver Diseases, deputy editor of my magazine Professor Wei Lai served as the Sixth Chinese Medical Association liver disease credits chairman. Wei Lai, male, born in November 1961, MD. IncumbentPeking UniversityPeople’s Hospital, vice president, Peking University Institute of liver disease, “Hepatitis C and Hepatitis Immunotherapy” Beijing Key Laboratory of Peking University People’s Hospital Director of liver disease, Professor, chief physician, PhD student tutor. And served as executive director of China Medical Biotechnology Association, the National Clinical Clinical Standards Committee of the Ministry of Health clinical application guidelines